56441-69-1

Basic information

• Product Name: 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER
• Synonyms: ETHYL 4-BENZYLOXYPHENYLACETATE;4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER;ethyl 2-[4-(benzyloxy)phenyl]acetate
• CAS NO: 56441-69-1
• Molecular Formula: C₁₇H₁₈O₃
• Molecular Weight: 270.32
• Mol File: 56441-69-1.mol
• Article Data: 7

Chemical Properties

• Melting Point: 29-31°C
• Boiling Point: 174/0.1mm
• Flash Point: 164℃
• Appearance: /
• Density: 1.110
• Vapor Pressure: 3.02E-06mmHg at 25°C
• Refractive Index: 1.553
• CAS DataBase Reference: 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER(56441-69-1)
• EPA Substance Registry System: 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER(56441-69-1)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 56441-69-1(Hazardous Substances Data)

Usage

General Description

4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER is a chemical compound consisting of an ester of 4-benzyloxyphenylacetic acid and ethanol. It is commonly used as a building block in organic synthesis and pharmaceutical research, particularly in the development of new drugs. 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER has potential applications in the fields of medicine and pharmacology due to its ability to modify and enhance the properties of certain drugs. Additionally, it is known for its anti-inflammatory and analgesic effects, making it a valuable substance for the development of pain-relief medications. Overall, 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER plays a pivotal role in the creation of various pharmaceutical compounds and has the potential to contribute to the advancement of medical treatments.

InChI:InChI=1/C17H18O3/c1-2-19-17(18)12-14-8-10-16(11-9-14)20-13-15-6-4-3-5-7-15/h3-11H,2,12-13H2,1H3

Upstream product

• 17138-28-2 (4-hydroxy-phenyl)-acetic acid ethyl ester 
• 100-44-7 benzyl chloride 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 100-39-0 benzyl bromide 
• 64-17-5 ethanol 
• 71749-20-7 1-Benzyloxy-4-((Z)-2-methanesulfinyl-2-methylsulfanyl-vinyl)-benzene 

Downstream Products

• 1126-93-8 2-ethoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 1454797-91-1 ethyl 2,3,3-tris(4-(benzyloxy)phenyl)propionate 
• 1258603-05-2 trans-5-(4-((2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazol-4-yl)methoxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258603-04-1 cis-5-(4-((2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazol-4-yl)methoxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258603-03-0 trans-5-(4-((5-methyl-6-((1-(pyrimidin-2-yl)piperidin-4-yl)oxy)pyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258603-02-9 cis-5-(4-((5-methyl-6-((1-(pyrimidin-2-yl)piperidin-4-yl)oxy)pyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258602-99-1 trans-5-(4-((6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258602-98-0 cis-5-(4-((6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 155062-29-6 2-[4-(benzyloxy)phenyl]-1,3-propanediol 
• 1258604-43-1 2-(4-((2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazol-4-yl)methoxy)phenyl)propane-1,3-diol 
• 1258604-42-0 4-((4-(2,2-dimethyl-1,3-dioxan-5-yl)phenoxy)methyl)-2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazole 
• 1258604-40-8 2-(4-(5-methyl-6-(1-(pyrimidin-2-yl)piperidin-4-yloxy)pyrimidin-4-yloxy)phenyl)propane-1,3-diol 

Relevant articles and documents

Boron-Catalyzed Azide Insertion of α-Aryl α-Diazoesters

A challenging metal-free azide insertion of α-aryl α-diazoesters in the presence of B(C6F5)3 (5 mol %) was developed for the first time. The reaction features an easy operation, wide substrate scope, and mild conditions an

1,2-disubstituted-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof

The invention relates to combinatorial libraries containing two or more novel piperidine-3-carboxamide derivative compounds, methods of preparing the piperidine-3-carboxamide derivative compounds and piperidine-3-carboxamide derivative compounds bound to a resin

Anti-glaucoma agent

1-{4-[2-(Cyclopropylmethoxy)-ethyl]-phenoxy}-3-isopropylamino-propan-2-ol and its pharmaceutically acceptable salts, in the form of a racemate or optical isomer, are useful as topical anti-glaucoma agents.